Inhaled Sargramostim (Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor) for COVID-19-Associated Acute Hypoxemia: Results of the Phase 2, Randomized, Open-Label Trial (iLeukPulm).

Saved in:
Bibliographic Details
Title: Inhaled Sargramostim (Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor) for COVID-19-Associated Acute Hypoxemia: Results of the Phase 2, Randomized, Open-Label Trial (iLeukPulm).
Authors: Paine R; Division of Respiratory, Critical Care and Occupational Pulmonary Medicine, University of Utah School of Medicine, Salt Lake City, UT 84132, USA., Chasse R; Department of Pulmonary and Critical Care, TidalHealth Peninsula Regional Medical Center, Salisbury, MD 21801, USA., Halstead ES; Division of Pediatric Critical Care Medicine, Department of Pediatrics, Penn State University, Hershey, PA 17033, USA., Nfonoyim J; Department of Medicine and Critical Care, Richmond University Medical Center, Staten Island, NY 10310, USA., Park DJ; Department of Hematology and Oncology, Providence St. Jude Medical Center, Fullerton, CA 92835, USA., Byun T; Department of Hematology and Medical Oncology, Providence St. Joseph Hospital, Orange, CA 92868, USA., Patel B; Department of Pulmonary, Critical Care and Sleep Medicine, University of Texas Health Science Center, Houston, TX 77030, USA., Molina-Pallete G; Department of Pulmonary and Critical Care, Great Plains Health, North Platte, NE 69101, USA., Harris ES; Division of Respiratory, Critical Care and Occupational Pulmonary Medicine, University of Utah School of Medicine, Salt Lake City, UT 84132, USA., Garner F; Partner Therapeutics, Inc., Lexington, MA 02421, USA., Simms L; Partner Therapeutics, Inc., Lexington, MA 02421, USA., Ahuja S; Partner Therapeutics, Inc., Lexington, MA 02421, USA., McManus JL; Partner Therapeutics, Inc., Lexington, MA 02421, USA., Roychowdhury DF; Partner Therapeutics, Inc., Lexington, MA 02421, USA.
Source: Military medicine [Mil Med] 2023 Jul 22; Vol. 188 (7-8), pp. e2629-e2638.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 2984771R Publication Model: Print Cited Medium: Internet ISSN: 1930-613X (Electronic) Linking ISSN: 00264075 NLM ISO Abbreviation: Mil Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1930-613X
DOI:10.1093/milmed/usac362